SECTOR GAMMA AS - Q1 2022 holdings

$460 Million is the total value of SECTOR GAMMA AS's 40 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 52.9% .

 Value Shares↓ Weighting
MRK BuyMERCK & CO INC$40,955,000
+12.3%
499,141
+4.9%
8.90%
+3.8%
GILD BuyGILEAD SCIENCES INC$40,517,000
+87.8%
681,538
+129.4%
8.80%
+73.6%
INCY BuyINCYTE CORP$35,105,000
+26.2%
442,012
+16.7%
7.63%
+16.7%
MDT BuyMEDTRONIC PLC$22,856,000
+8.2%
206,006
+0.9%
4.97%
-0.0%
BIIB BuyBIOGEN INC$17,258,000
+8.0%
81,945
+23.0%
3.75%
-0.2%
CNC BuyCENTENE CORP DEL$16,389,000
+8.6%
194,664
+6.3%
3.56%
+0.4%
BRKR BuyBRUKER CORP$16,201,000
+18.6%
251,952
+54.8%
3.52%
+9.7%
NUVA BuyNUVASIVE INC$15,084,000
+19.4%
266,035
+10.5%
3.28%
+10.4%
CI BuyCIGNA CORP NEW$13,986,000
+46.8%
58,370
+40.7%
3.04%
+35.7%
QGEN BuyQIAGEN NV$10,742,000
-1.8%
219,226
+11.4%
2.33%
-9.3%
ALNY NewALNYLAM PHARMACEUTICALS INC$9,675,00059,251
+100.0%
2.10%
ELAN BuyELANCO ANIMAL HEALTH INC$9,515,000
-2.9%
364,691
+5.6%
2.07%
-10.2%
ZBH NewZIMMER BIOMET HOLDINGS INC$8,288,00064,801
+100.0%
1.80%
AZN NewASTRAZENECA PLCsponsored adr$8,226,000124,000
+100.0%
1.79%
BIO BuyBIO RAD LABS INCcl a$7,201,000
-18.1%
12,785
+9.8%
1.56%
-24.3%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$6,880,000
+17.3%
47,467
+4.9%
1.50%
+8.4%
ITCI NewINTRA-CELLULAR THERAPIES INC$4,947,00080,843
+100.0%
1.08%
PDCO BuyPATTERSON COS INC$4,200,000
+16.4%
129,757
+5.5%
0.91%
+7.7%
SAGE BuySAGE THERAPEUTICS INC$3,922,000
-6.8%
118,476
+19.8%
0.85%
-13.9%
RARE NewULTRAGENYX PHARMACEUTICAL IN$3,357,00046,221
+100.0%
0.73%
PTCT NewPTC THERAPEUTICS INC$2,980,00079,864
+100.0%
0.65%
NVAX BuyNOVAVAX INC$2,823,000
+47.9%
38,324
+187.2%
0.61%
+36.5%
QTRX NewQUANTERIX CORP$2,588,00088,670
+100.0%
0.56%
NewSOMALOGIC INC$2,416,000301,224
+100.0%
0.52%
VIR BuyVIR BIOTECHNOLOGY INC$2,063,000
+12.0%
80,223
+82.3%
0.45%
+3.5%
ATRA NewATARA BIOTHERAPEUTICS INC$1,149,000123,713
+100.0%
0.25%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BOSTON SCIENTIFIC CORP40Q1 20239.9%
BIO RAD LABS INC40Q1 20234.7%
BRISTOL-MYERS SQUIBB CO38Q3 202311.9%
BAXTER INTL INC34Q3 202312.7%
CARDINAL HEALTH INC34Q3 20238.1%
PERKINELMER INC33Q2 20216.3%
BIOGEN INC30Q3 20237.6%
ELEVANCE HEALTH INC30Q3 20235.6%
GILEAD SCIENCES INC29Q3 202314.0%
TENET HEALTHCARE CORP28Q3 20234.3%

View SECTOR GAMMA AS's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-11-06
13F-HR2023-08-09
13F-HR2023-05-12
13F-HR/A2023-02-08
13F-HR2023-02-07
13F-HR2022-11-09
13F-HR2022-08-05
13F-HR2022-05-06
13F-HR2022-02-08

View SECTOR GAMMA AS's complete filings history.

Compare quarters

Export SECTOR GAMMA AS's holdings